Corcept Therapeutics
CORT
#3286
Rank
A$6.34 B
Marketcap
A$59.62
Share price
2.06%
Change (1 day)
-52.10%
Change (1 year)

Earnings for Corcept Therapeutics (CORT)

Earnings in 2025 (TTM): A$68.18 Million

According to Corcept Therapeutics 's latest financial reports the company's current earnings are A$0.76 Billion. a decrease over its 2024 earnings that were of A$0.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corcept Therapeutics from 2003 to 2025

Annual earnings

Year Earnings Change
2025 A$64.06 M-67.29%
2024 A$0.19 B27.66%
2023 A$0.15 B-4.75%
2022 A$0.16 B-9.51%
2021 A$0.17 B-2.91%
2020 A$0.18 B14.87%
2019 A$0.15 B24.71%
2018 A$0.12 B69.32%
2017 A$75.58 M419.26%
2016 A$14.55 M-395.64%
2015 -A$4.93 Million-87.53%
2014 -A$39.5 Million-33.44%
2013 -A$59.35 Million
2011 -A$46.24 Million17.84%
2010 -A$39.24 Million35.5%
2009 -A$28.96 Million2.84%
2008 -A$28.16 Million60.81%
2007 -A$17.51 Million-52.14%
2006 -A$36.59 Million20.91%
2005 -A$30.26 Million31.87%
2004 -A$22.95 Million60.54%
2003 -A$14.3 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$47.98 B 74,797.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$23.38 B 36,402.44%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$14.57 B 22,651.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$36.79 B 57,339.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$32.06 B 49,954.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$13.33 B 20,722.82%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
A$44.02 M-31.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-A$39.25 Million-161.26%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$0.68 B 977.04%๐Ÿ‡บ๐Ÿ‡ธ USA